Delivery Order SPE2DE24DA010-SPE2D625F2NQT
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order (Contract No. 4568634478, GALLANT) by the Medical Supply Chain division of the Department of Defense on June 20, 2025, with an ultimate completion date of June 25, 2025. The contract, valued at $30,281.95, carries no set-aside designation, indicating full and open competition. Performance will occur at Abbott's facility in Santa Clara, California. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $51.3K by the Medical Supply Chain, a defense-focused federal agency, on July 16, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 21, 2025, and will be performed in Santa Clara, California. The contract was awarded under full and open competition with no set-aside designation, indicating Abbott competed against other...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order (Contract No. 4569302326) valued at $9,243.00 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025, with an ultimate completion date of September 8, 2025. The contract utilizes fixed-price pricing with economic price adjustment and does not include a set-aside designation, indicating full and open competition. Performance will take place in Santa Clara, California. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $5,495 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025, with an ultimate completion date of August 4, 2025. This delivery order, which contains no set-aside designation indicating full and open competition, represents a call against a larger indefinite delivery contract vehicle. The work will be performed in Santa Clara, California, and involves the...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract (No. 4569147994, titled "GALLANT") by the Department of Defense Medical Supply Chain on August 19, 2025, with a ceiling value of $38,345.80. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 22, 2025, and will be performed in Santa Clara, California. The contract was awarded without set-aside designation, indicating full...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350.00 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as AVEIR (a reference to Abbott's Aveir Leadless Pacemaker technology), will be performed in Santa Clara, California, and was awarded without a set-aside designation, indicating full and open competition. This...
- The U.S. government has awarded a $33,000.00 fixed-price delivery order contract to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer, through its Abbott Vascular Inc. division. The contract, awarded by the Defense Logistics Agency's Medical Supply Chain program, is for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. This contract does not...
- This is a $8,428.00 fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency to Abbott Laboratories Inc., through its Abbott Vascular Inc. division. The contract is for the delivery of various cardiovascular medical devices and related services, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The award has an ultimate completion date of February 12, 2025. This...
- This federal contract award was issued by the Medical Supply Chain, a Defense agency, to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $25,715.85 fixed-price delivery order contract, awarded on July 9, 2025, has an ultimate completion date of July 14, 2025 and does not utilize a set-aside designation. The contract requires Abbott Laboratories to provide a range of cardiovascular medical devices and technologies, including stents, pacemakers, heart valves, implantable...
- This federal contract award, valued at $24,350.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc.'s Abbott Vascular Inc. division. The award is a fixed-price delivery order contract for the delivery of cardiovascular medical devices and related services, such as electrophysiology catheters, heart valve prosthetics, surgical implants, cardiac mapping systems, and neuromodulation devices. The contract has an ultimate completion...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F2NQTDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $1,120.00 by the Medical Supply Chain division of the Department of Defense on September 4, 2025, with an ultimate completion date of September 9, 2025. This fixed-price contract with economic price adjustment authority will be performed in Santa Clara, California. The award represents a continuation of Abbott's extensive role as a critical supplier of advanced cardiovascular medical technologies to federal healthcare systems, with no set-aside designation applied, indicating full and open competition. This delivery order is part of Abbott's broader engagement with federal procurement channels, particularly through the Defense Logistics Agency's Medical Supply Chain. Abbott Laboratories Inc. has established itself as a strategic supplier of sophisticated cardiovascular devices and related medical technologies to the Department of Defense and Department of Veterans Affairs, with prior contract awards encompassing advanced products such as stents, pacemakers, heart valves, and specialized surgical implants. The company's federal contracting history demonstrates its capability to deliver comprehensive medical solutions, including devices, instrumentation, and accessories, typically through indefinite delivery vehicles and blanket purchase agreements ranging in value from thousands to millions of dollars.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/4/25 |